PRPO
BEARISH
$28.3
Live
Precipio, Inc. · NASDAQ
$5.24
52W Range
$29.8
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 18, 2026
Market cap
$50.48M
P/E
N/A
ROE
-2.7%
Profit margin
-1.5%
Debt/Equity
0.25
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
85%
PRPO exhibits a severe disconnect between its recent price appreciation (+381% 1Y) and its fundamental health, highlighted by a critical Piotroski F-Score of 2/9. While the company shows promising top-line growth (22.9% YoY) and a positive operating margin (8.09%), it remains net-unprofitable with a prohibitively high Forward P/E of 72.56. The technical trend has collapsed to 10/100, suggesting the recent rally was speculative and is now reversing. Overall, the combination of weak deterministic health scores and extreme valuation makes the current price unsustainable.
Key Strengths
Strong revenue growth of 22.9% YoY
Positive operating margin of 8.09% indicating core business viability
Low Debt/Equity ratio (0.25) suggesting manageable leverage
Recent improvement in earnings surprises (3/4 beats in last 4 quarters)
Healthy liquidity with a Current Ratio of 1.61
Key Risks
Critical Piotroski F-Score (2/9) indicating poor financial strength
Extreme valuation with a Forward P/E of 72.56
Negative net profit margin (-1.51%) and negative ROE (-2.72%)
Severe bearish technical trend (10/100) following a speculative spike
Micro-cap volatility and lack of analyst coverage
AI Fair Value Estimate
Based on comprehensive analysis
$14.5
-48.8% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
26
Weak
20
65
30
15
0
AI Verdict
Speculative/Overvalued
Key drivers: Piotroski F-Score, Forward P/E, Technical Trend, Revenue Growth
Confidence
90%
Value
20/100
Ref Forward P/E and lack of Graham Number due to negative earnings
Positives
- P/S ratio of 2.10 is relatively modest
Watchpoints
- Forward P/E of 72.56 is excessive
- Price/Book of 3.46 is high for a non-profitable micro-cap
Future
65/100
Ref Growth rates and recent EPS surprises
Positives
- 22.9% YoY Revenue growth
- 62.9% YoY EPS growth
- Improving earnings track record
Watchpoints
- Still struggling to achieve consistent net profitability
Past
30/100
Ref Historical earnings progression and 5Y price change
Positives
- Massive 1-year price appreciation
Watchpoints
- History of significant earnings misses (e.g., 2022-05-11)
- Long-term 5Y change is negative (-22.7%)
Health
15/100
Ref Piotroski F-Score
Positives
- Low Debt/Equity (0.25)
- Current Ratio > 1.5
Watchpoints
- Piotroski F-Score of 2/9 is a major red flag for financial distress
Dividend
0/100
Ref Dividend Yield and Payout Ratio
Positives
No standout positives identified.
Watchpoints
- No dividend paid
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$28.3
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for PRPO and closest competitors.
Updated 2026-04-17
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
PRPO
Precipio, Inc.
Primary
|
-22.7% | +116.7% | +381.3% | +64.1% | -0.9% | +3.9% |
|
PETS
PetMed Express, Inc.
Peer
|
-91.2% | -84.4% | -23.0% | -7.9% | -8.2% | +1.3% |
|
HYFT
MindWalk Holdings Corp.
Peer
|
-91.3% | -62.5% | +166.8% | -40.9% | -16.4% | -6.1% |
|
NTRB
Nutriband Inc.
Peer
|
-28.9% | +17.2% | -16.9% | -45.8% | +7.4% | +4.1% |
|
POCI
Precision Optics Corporation, Inc.
Peer
|
-7.8% | -29.0% | +17.5% | +13.0% | +13.2% | +17.8% |
PRP
Precipio, Inc.
Primary
5Y
-22.7%
3Y
+116.7%
1Y
+381.3%
6M
+64.1%
1M
-0.9%
1W
+3.9%
PET
PetMed Express, Inc.
Peer
5Y
-91.2%
3Y
-84.4%
1Y
-23.0%
6M
-7.9%
1M
-8.2%
1W
+1.3%
HYF
MindWalk Holdings Corp.
Peer
5Y
-91.3%
3Y
-62.5%
1Y
+166.8%
6M
-40.9%
1M
-16.4%
1W
-6.1%
NTR
Nutriband Inc.
Peer
5Y
-28.9%
3Y
+17.2%
1Y
-16.9%
6M
-45.8%
1M
+7.4%
1W
+4.1%
POC
Precision Optics Corporation, Inc.
Peer
5Y
-7.8%
3Y
-29.0%
1Y
+17.5%
6M
+13.0%
1M
+13.2%
1W
+17.8%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
72.56
PEG Ratio
N/A
P/B Ratio
3.46
P/S Ratio
2.1
EV/Revenue
2.14
EV/EBITDA
222.86
Market Cap
$50.48M
Profitability
Profit margins and return metrics
Profit Margin
-1.51%
Operating Margin
8.09%
Gross Margin
44.52%
ROE
-2.72%
ROA
-3.92%
Growth
Revenue and earnings growth rates
Revenue Growth
+22.9%
Earnings Growth
N/A
Q/Q Revenue Growth
+22.92%
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.25
Low debt
Current Ratio
1.61
Good
Quick Ratio
1.24
Good
Cash/Share
$1.49
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$0.0B
Gross Margin
46.8%
Op. Margin
8.1%
Net Margin
7.9%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.46x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
80%
Quarterly Earnings History
EPS performance vs analyst estimates
2023-11-13
$-1.04
+25.7% surprise
2023-08-11
$-1.8
+10.0% surprise
2023-05-12
$-2.6
2023-03-30
$-2.0
+28.6% surprise
Healthcare Sector Comparison
Comparing PRPO against 418 companies in the Healthcare sector
(24 bullish, 134 neutral, 260 bearish)
Return on Equity (ROE)
-2.72%
This Stock
vs
-101.05%
Sector Avg
-97.3%
(Below Avg)
Profit Margin
-1.51%
This Stock
vs
-13.75%
Sector Avg
-89.0%
(Weaker)
Debt to Equity
0.25
This Stock
vs
3.24
Sector Avg
-92.2%
(Less Debt)
Revenue Growth
22.9%
This Stock
vs
121.5%
Sector Avg
-81.2%
(Slower)
Current Ratio
1.61
This Stock
vs
4.55
Sector Avg
-64.6%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
PRPO
Precipio, Inc.
|
BEARISH | $50.48M | - | -2.7% | -1.5% | $28.3 | |
|
PETS
PetMed Express, Inc.
|
BEARISH | $50.08M | - | -100.6% | -34.7% | $2.34 | Compare |
|
HYFT
MindWalk Holdings Corp.
|
BEARISH | $49.98M | - | -58.8% | -43.6% | $1.07 | Compare |
|
NTRB
Nutriband Inc.
|
BEARISH | $49.67M | - | -136.1% | -% | $4.08 | Compare |
|
POCI
Precision Optics Corporation, Inc.
|
BEARISH | $51.36M | - | -73.6% | -28.3% | $4.7 | Compare |
PRPO
Precipio, Inc.
BEARISH
Mkt Cap
$50M
P/E
-
ROE
-2.7%
Price
$28.3
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | SABET AHMED ZAKI | Chief Operating Officer | Purchase | 19 | $531 |
| 2026-01-15 | LAPORTE KATHLEEN D | Director | Stock Award | 520 | $12,480 |
| 2026-01-15 | COHEN DAVID SETH | Director | Stock Award | 546 | $13,104 |
| 2026-01-15 | COSSMAN JEFFREY M.D. | Director | Stock Award | 437 | $10,488 |
| 2026-01-15 | VALAURI CHRISTINA RIZOPOULOS | Director | Stock Award | 406 | $9,744 |
| 2026-01-02 | SABET AHMED ZAKI | Chief Operating Officer | Purchase | 20 | $468 |
| 2026-01-02 | SABET AHMED ZAKI | Chief Operating Officer | Purchase | 20 | $468 |
SABET AHMED ZAKI
Chief Operating Officer
2026-04-01
19 shares
·
$531
LAPORTE KATHLEEN D
Director
2026-01-15
520 shares
·
$12,480
COHEN DAVID SETH
Director
2026-01-15
546 shares
·
$13,104
COSSMAN JEFFREY M.D.
Director
2026-01-15
437 shares
·
$10,488
VALAURI CHRISTINA RIZOPOULOS
Director
2026-01-15
406 shares
·
$9,744
SABET AHMED ZAKI
Chief Operating Officer
2026-01-02
20 shares
·
$468
SABET AHMED ZAKI
Chief Operating Officer
2026-01-02
20 shares
·
$468
Insider transactions can signal confidence or concerns about company prospects
SEC Filings
Recent regulatory filings from the SEC EDGAR database
10-K
8-K
8-K
10-Q
8-K
10-Q
8-K
Data sourced from SEC EDGAR. AI summaries generated automatically.
Past News Coverage
Recent headlines mentioning PRPO from our newsroom.
Newest → oldest
No matching news yet.